Cell Therapy Raw Materials Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029

  • Published: Apr 2025
  • Pages: 160

Cell Therapy Raw Materials Market Size 2025-2029

The cell therapy raw materials market is expected to grow by USD 4-7 billion at a CAGR of 17%-20% between 2025 and 2029. Exact values for this market can be accessed upon purchasing the report.

The market is expected to grow rapidly in the forecast period due to the increasing demand for bioprocessing materials such as culture media, growth factors, cytokines, and extracellular matrix (ECM) components. The surge in biopharmaceutical research and advancements in cell-based therapies, including stem cell and CAR-T cell therapies, are expected to drive growth. Factors such as rising investments in clinical trials, regulatory advancements, and an increasing number of hospitals adopting regenerative treatments are expected to contribute significantly to market expansion.

To access the full market forecast and comprehensive analysis, Buy Now

How is this Market Segmented?

info_market_segment

The market research report provides comprehensive data, including region-wise segment analysis, with forecasts and estimates in USD billion for the period 2025-2029, along with historical data for the following segments:

  • Type
    • Stem Cell-based Raw Materials
    • Gene Therapy Raw Materials
    • CAR-T Cell Therapy Raw Materials
  • End-use
    • Research and Development
    • Clinical Trials
    • Commercial Manufacturing
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
    • South America
      • Brazil
    • Middle East and Africa

Type Insights

The market for stem cell-based raw materials is witnessing significant growth, as these materials are key to developing therapies for a wide range of conditions, including neurodegenerative disorders and cardiovascular diseases. Similarly, raw materials used in CAR-T therapies are gaining traction, driven by innovations in immunotherapy. With technological advancements improving production processes, the demand for highly specialized culture media and growth factors is on the rise. The competition is intense, with leading companies in the sector developing differentiated products to meet the growing needs of cell-based therapies.

Regional Analysis

The North American market is expected to dominate the global cell therapy raw materials market, driven by a high concentration of biotechnology and pharmaceutical companies and a large number of clinical trials. The presence of top research universities and favorable government policies in the US further enhance the region’s growth prospects. Meanwhile, the Asia Pacific market, particularly in countries like China and India, is anticipated to see rapid growth due to increasing investments in biotechnology and cell-based therapies, along with a growing patient pool requiring treatment.

Market Dynamics

Our cell therapy raw materials researchers have analyzed the data with 2024 as the base year, focusing on key drivers, trends, and challenges to provide actionable insights into the market.

What are the Key Market Drivers Leading to the Rise in Adoption of Cell Therapy Raw Materials Market?

Increasing adoption of cell-based therapies is a key driver for the growth of the market. With the rise of chronic diseases, autoimmune conditions, and cancer, the demand for effective treatments is growing. As cell therapies like CAR-T, stem cell, and gene therapies continue to show promise in clinical trials, they create higher demand for specialized raw materials. Technological advancements in cell culture technologies, as well as improved production techniques for high-quality raw materials, will likely propel market growth.

What Are the Market Trends Shaping the Cell Therapy Raw Materials Market?

There is a growing trend towards the use of clean, high-quality raw materials. Manufacturers are focusing on optimizing production processes to improve product yields and reduce production costs, which in turn is improving the accessibility of therapies. Innovations in cryopreservation and bioreactor technologies are also shaping the market, with companies aiming to streamline the manufacturing process and reduce material waste. Furthermore, the increased focus on personalized medicine and the growing importance of regenerative medicine are contributing to the surge in demand for specialized raw materials.

What Challenges Does the Cell Therapy Raw Materials Market Face?

The market faces challenges including the high cost of raw materials and stringent regulatory approvals. As the raw materials required for cell therapies are often complex and expensive to produce, the overall cost of developing therapies increases. The lack of standardized manufacturing processes and quality control issues further complicate the scalability of cell therapy products. Additionally, navigating regulatory hurdles in various countries can delay the market’s growth potential, with the need for compliance with local and international standards.

Key Companies & Market Insights

Companies in the cell therapy raw materials market are implementing strategies such as partnerships, technological advancements, and geographical expansion to maintain competitive advantages. This market research report includes detailed analyses of the competitive landscape of the market and information on close to 20 key companies, including:

  • Lonza Group
  • Merck KGaA
  • Becton Dickinson
  • Fujifilm Irvine Scientific
  • Sartorius AG
  • Thermo Fisher Scientific
  • Bio-Techne
  • Selexis
  • Invitrogen
  • Corning Incorporated

These companies are innovating by expanding their product portfolios and focusing on the development of cutting-edge technologies to meet the evolving needs of the cell therapy industry.

Market Scope

Base Year

      2024

Forecast Period

      2025-2029

Market Size

      USD 4-7 Billion

Market Growth

      17%-20%

Type

  • Stem Cell-based Raw Materials
  • Gene Therapy Raw Materials
  • CAR-T Cell Therapy Raw Materials

End-Use

  • Research and Development
  • Clinical Trials
  • Commercial Manufacturing

Regional Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa

Key Companies Profiled

  • Lonza Group
  • Merck KGaA
  • Becton Dickinson
  • Fujifilm Irvine Scientific
  • Sartorius AG
  • Thermo Fisher Scientific
  • Bio-Techne
  • Selexis
  • Invitrogen
  • Corning Incorporated
  • Others

For further information, Get Free Sample

How the Benefits of a Technavio Market Research Report Can Empower Your Business

Technavio’s reports provide a range of market insights, including:

  • A detailed analysis of the market, featuring market size, growth rate, segmentation, and regional performance
  • In-depth analysis of the drivers, challenges, and other dynamics that will impact the growth of the market
  • Predictions about upcoming trends and changes in consumer behavior
  • Detailed information on key market players, including market positioning, product offerings, and more

 

Image
Cell Therapy Raw Materials Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029
Interested in this report?
Get your sample now!